Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ocugen, Inc.

NASDAQ: OCGN · Life Sciences · 10 alerts · CIK 1372299

Ocugen, Inc. stories on ALFA USA NewsRead the news →
Share price
$0.7730Close, Nov 16
Market cap
$262M
Shares outstanding
339.31MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ocugen, Inc. filings on SEC EDGAR ↗

8:01 AM ET 8-K
Investor Presentation

Ocugen Investor Presentation

Ocugen, Inc. filed a formal investor presentation deck for October 2026 detailing its strategic pipeline and clinical milestones. The company is targeting three Biologics License Applications (BLAs) by 2028 for its gene therapy candidates OCU400, OCU410, and OCU410ST, which address major blindness diseases.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.